BGI Group, the world's largest genomics company, has worked with China's military on research that ranges from mass testing for respiratory pathogens to brain science, a review of research, patent filings and other documents has found.
The review, of more than 40 publicly available documents and research papers in Chinese and English, shows BGI’s links to the People’s Liberation Army (PLA) include research with China’s top military supercomputing experts. The extent of those links has not previously been reported.
BGI has sold millions of COVID-19 test kits outside China since the outbreak of the new coronavirus pandemic, including to Europe, Australia and the United States. Shares of BGI Genomics Co., the company’s subsidiary listed on the Shenzhen stock exchange, have doubled in price over the past 12 months, giving it a market value of about $9 billion.
With your current subscription plan you can comment on stories. However, before writing your first comment, please create a display name in the Profile section of your subscriber account page.